CompletedNot Applicable

Effects of Preoperative Rehabilitation in Patients Resected for Lung Cancer

France90 participantsStarted 2017-05-12

Plain-language summary

This randomized controlled trial will evaluate the effect of a preoperative rehabilitation program at home in patients resected for lung cancer, comparing a control group (C group) receiving only chest physiotherapy and a rehabilitation group (R group) receiving both a training program at home and chest physiotherapy

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients diagnosed for lung cancer (or highly suspicious for cancer tumor) eligible for resection surgery (lobectomy or pneumonectomy) * Age \> 18 years * Presence of Chronic Obstructive Pulmonary Disease (COPD) stages 2-4 of Gold (forced expiratory volume (FEV )/ forced vital capacity (FVC) \<70%, FEV \<80% of predicted) and Exertional dyspnea stage MMRC (Medical Research Council) \> 1 * Patients must provide written consent * Member of social security scheme Exclusion Criteria: * Patients refusing to participate * COPD stage 1 Gold (VEMS \>= 80% of the theoretical value) * Presenting an operating contraindication during the initial maximal exercise test * Presenting cardiac or vascular contraindication to achieve the readaptation program * Patient living alone at home * Patient with ventilatory assistance at home (oxygen therapy or noninvasive ventilation (NIV)) * With exercise hypoventilation (PaCO2 \>45 mmHg) * Cognitive difficulty * unable major * pregnancy, * patients deprived of liberty by a court or administrative decision

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Hospital length of stay after resection for lung cancer

Timeframe: time from the date of the surgery (Day 0) until the date of discharge (Day n) (assessed up to 56 days)

Trial details

NCT IDNCT03020251

SponsorCentre Jean Perrin

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-02-13

View on ClinicalTrials.gov More Lungcancer trials